TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Redo Biosolutions AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
10,663
|
13,342
|
11,808 |
| Financial expenses |
23
|
0
|
1 |
| Earnings before taxes |
236
|
2,339
|
2,342 |
| EBITDA |
511
|
2,709
|
2,614 |
| Total assets |
21,376
|
9,815
|
7,489 |
| Current assets |
14,680
|
7,147
|
4,481 |
| Current liabilities |
11,886
|
3,520
|
3,176 |
| Equity capital |
9,351
|
6,166
|
4,313 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
5
|
4
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
43.7%
|
62.8%
|
57.6% |
| Turnover per employee |
2,133
|
3,336
|
3,936 |
| Profit as a percentage of turnover |
2.2%
|
17.5%
|
19.8% |
| Return on assets (ROA) |
1.2%
|
23.8%
|
31.3% |
| Current ratio |
123.5%
|
203.0%
|
141.1% |
| Return on equity (ROE) |
2.5%
|
37.9%
|
54.3% |
| Change turnover |
-2,225
|
1,499
|
6,253 |
| Change turnover % |
-17%
|
13%
|
113% |
| Chg. No. of employees |
1
|
1
|
3 |
| Chg. No. of employees % |
25%
|
33% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.